Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot

Abstract

Tetralogy of Fallot patients have a higher risk of inappropriate therapies and other complications yet a lower incidence of appropriate therapies from their ICD than DCM patients. Further research into identification of factors predicting SCD in TOF and the benefits of ICD implantation is essential given the potential complications of ICD implantation in young congenital heart disease patients.